Duoning Biotech announces strategic partnership with Branca Bunús for transfection reagents development

Nov 06, 2024•about 1 year ago

Contract Type

partnership

BiotechnologyManufacturing

Description

Duoning Biotechnology Group has announced a strategic partnership agreement with Branca Bunús Ltd. to collaborate on the development, optimization, and application of transfection reagents. This partnership aims to enhance the efficiency of biopharmaceutical development in upstream bioprocess by providing innovative transfection reagents to biopharmaceutical customers.

Company Information

Company

Duoning Biotech

About

Shanghai Duoning Biotechnology Co., Ltd. is a leading one-stop shop dedicated to providing integrated bioprocess solutions from the development to the commercialization of biologics products in China. We operate two business lines, bioprocess solutions and laboratory products and relative services, and seek to help partners achieve efficient, stable, high-quality and cost-controllable drug development and manufacturing processes. For more information, please visit: www.duoningbio.com.

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months